These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9169660)

  • 21. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow lambda-type light chain crystalline structures associated with multiple myeloma.
    Schvartz H; Bonhomme P; Caulet S; Beorchia A; Patey M; Caulet T
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):449-56. PubMed ID: 3931345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
    Chakraborty R; Muchtar E; Kumar SK; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
    Leuk Lymphoma; 2017 Feb; 58(2):308-315. PubMed ID: 27390076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients.
    Auberger J; Clausen J; Kircher B; Kropshofer G; Lindner B; Nachbaur D
    Eur J Haematol; 2011 Dec; 87(6):531-8. PubMed ID: 21848700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Light chain escape followed by leukemic transformation in a patient with IgD myeloma].
    Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2015 Jan; 56(1):48-50. PubMed ID: 25745970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.
    Pratt G; Mead GP; Godfrey KR; Hu Y; Evans ND; Chappell MJ; Lovell R; Bradwell AR
    Leuk Lymphoma; 2006 Jan; 47(1):21-8. PubMed ID: 16321823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression.
    Fernández de Larrea C; Tovar N; Rozman M; Rosiñol L; Aróstegui JI; Cibeira MT; Rovira M; Yagüe J; Bladé J
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1084-7. PubMed ID: 21215814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.
    Frankel W; Chan A; Corringham RE; Shepherd S; Rearden A; Wang-Rodriguez J
    Am J Hematol; 1996 Aug; 52(4):281-7. PubMed ID: 8701946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
    Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Therneau TM; Kyle RA; Greipp PR; Gertz MA
    Am J Hematol; 2001 Dec; 68(4):269-75. PubMed ID: 11754416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
    Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
    Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of immunohistologic stains for immunoglobulin light chains in bone marrow biopsies in benign and malignant plasma cell proliferations.
    Wolf BC; Brady K; O'Murchadha MT; Neiman RS
    Am J Clin Pathol; 1990 Dec; 94(6):742-6. PubMed ID: 2123076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
    Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation.
    Harada K; Akai Y; Sakan H; Yamaguchi Y; Nakatani K; Iwano M; Saito Y
    Clin Nephrol; 2010 Nov; 74(5):384-8. PubMed ID: 20979947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.
    Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.
    Liu H; Yuan C; Heinerich J; Braylan R; Chang M; Wingard J; Moreb J
    Leuk Lymphoma; 2008 Feb; 49(2):306-14. PubMed ID: 18231918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation.
    Sukpanichnant S; Cousar JB; Leelasiri A; Graber SE; Greer JP; Collins RD
    Hum Pathol; 1994 Mar; 25(3):308-18. PubMed ID: 8150462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.